Durability of platelet response after switching to avatrombopag from eltrombopag or romiplostim in immune thrombocytopenia

被引：1
|
作者：
Al-Samkari, Hanny [1 ,2 ,9 ]
Jiang, Debbie [3 ,4 ]
Gernsheimer, Terry [3 ,4 ]
Liebman, Howard [5 ]
Lee, Susie [5 ]
Bernheisel, Chelsea
Wojdyla, Matthew [6 ]
Vredenburg, Michael [6 ]
Cuker, Adam [7 ,8 ]
机构：
[1] Massachusetts Gen Hosp, Div Hematol, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Univ Washington, Div Hematol, Seattle, WA USA
[4] Seattle Canc Care Alliance, Seattle, WA USA
[5] Univ Southern Calif, Keck Sch Med, Hematol, Los Angeles, CA USA
[6] Sobi Inc, Durham, NC USA
[7] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA USA
[8] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA USA
[9] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA
来源：
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS | 2023年 / 7卷 / 03期
关键词：
avatrombopag; eltrombopag; immune thrombocytopenia; romiplostim; thrombopoietin receptor;
D O I：
10.1016/j.rpth.2023.100134
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Durability of Platelet Response When Switching from Eltrombopag or Romiplostim to Avatrombopag in Immune Thrombocytopenia (ITP): A Multicenter Study
    Al-Samkari, Hanny
    Jiang, Debbie
    Gernsheimer, Terry B.
    Liebman, Howard A.
    Lee, Susie
    Bernheisel, Chelsea
    Kolodny, Scott
    Wojdyla, Matthew
    Vredenburg, Michael
    Jamieson, Brian
    Cuker, Adam
    BLOOD, 2021, 138
  • [2] Interim Analysis of Platelet Response in a Prospective Phase 4 Study in Adult Immune Thrombocytopenia (ITP) Subjects after Switching from Eltrombopag (ELT) or Romiplostim (ROMI) to Avatrombopag (AVA)
    Tarantino, Michael D.
    Kolodny, Scott
    Zhang, Jessica
    Jamieson, Brian
    Vredenburg, Michael
    BLOOD, 2023, 142
  • [3] Interim Analysis of Treatment Satisfaction from a Prospective Phase 4 Study in Adult Immune Thrombocytopenia (ITP) Subjects after Switching from Eltrombopag or Romiplostim to Avatrombopag
    Tarantino, Michael D.
    Kolodny, Scott
    Zhang, Jessica
    Jamieson, Brian
    Vredenburg, Michael
    BLOOD, 2023, 142
  • [4] Use of eltrombopag after romiplostim in primary immune thrombocytopenia
    Ramon Gonzalez-Porras, Jose
    Eva Mingot-Castellano, Maria
    Andrade, Marcio M.
    Alonso, Rafael
    Caparros, Isabel
    Carmen Arratibel, Maria
    Fernandez-Fuertes, Fernando
    Jose Cortti, Maria
    Pascual, Cristina
    Sanchez-Gonzalez, Blanca
    Bernat, Silvia
    Angel Fuertes-Palacio, Miguel
    Andres Vazquez-Paganini, Juan
    Olivera, Pavel E.
    Teresa Alvarez-Roman, Maria
    Jarque, Isidro
    Cortes, Montserrat
    Martinez-Robles, Violeta
    Javier Diaz-Galvez, Francisco
    Calbacho, Maria
    Fernandez-Minano, Carmen
    Garcia-Frade, Javier
    Jose Gonzalez-Lopez, Tomas
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (01) : 111 - 116
  • [5] Relative potency of the thrombopoietin receptor agonists eltrombopag, avatrombopag and romiplostim in a patient with chronic immune thrombocytopenia
    Al-Samkari, Hanny
    Kuter, David J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (02) : 168 - 168
  • [6] Switching From Romiplostim to Eltrombopag or Vice Versa for Immune Thrombocytopenia: Efficacy and Safety in 46 Patients
    Khellaf, Mehdi
    Viallard, Jean-Francois
    Hamidou, Mohamed
    Cheze, Stephane
    Lefrere, Francois
    Fain, Olivier
    Audia, Sylvain
    Jardin, Fabrice
    Gyan, Emmanuel
    Durand, Jean Marc
    Haioun, Corinne
    Bierling, Philippe
    Michel, Marc
    Godeau, Bertrand
    BLOOD, 2012, 120 (21)
  • [7] Thrombopoietin Level Predicts Response to Treatment with Eltrombopag and Romiplostim in Immune Thrombocytopenia
    Al-Samkari, Hanny
    Kuter, David J.
    BLOOD, 2018, 132
  • [8] Thrombopoietin level predicts response to treatment with eltrombopag and romiplostim in immune thrombocytopenia
    Al-Samkari, Hanny
    Kuter, David J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (12) : 1501 - 1508
  • [9] Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study
    Al-Samkari, Hanny
    Jiang, Debbie
    Gernsheimer, Terry
    Liebman, Howard
    Lee, Susie
    Wojdyla, Matthew
    Vredenburg, Michael
    Cuker, Adam
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 (03) : 359 - 366
  • [10] Real-World Use, Effectiveness and Safety of Romiplostim, Eltrombopag and Avatrombopag in Immune Thrombocytopenia: Data from the Norwegian ITP Registry
    Tomasello, Riccardo
    Garabet, Lamya
    Pettersen, Heidi
    Tjonnfjord, Eirik
    Tsykunova, Galina
    Pedersen, Torkild
    Tran, Hoa
    Napolitano, Mariasanta
    Ghanima, Waleed
    BLOOD, 2023, 142
12345